Idiopathic Pulmonary Fibrosis — Trial Of IW001 in Patients With Idiopathic Pulmonary Fibrosis
Citation(s)
A Phase One, Open Label, Multi-Dose Study to Evaluate the Safety, Tolerability, and Biologic Effects of Three Doses of IW001 in Patients With Idiopathic Pulmonary Fibrosis (IPF)